Researcher
Da Hae Lee
- Disciplines:Endocrinology and metabolic diseases
Affiliations
- Clinical and Experimental Endocrinology (Division)
Member
From5 Aug 2011 → 15 Jun 2021
Publications
1 - 10 of 11
- SLC30A8 polymorphism and BMI complement HLA-A*24 as risk factors for poor graft function in islet allograft recipients(2018)
Authors: Da Hae Lee, Pieter Gillard
Pages: 1623 - 1632 - Age and early graft function relate with risk-benefit ratio of allogenic islet transplantation under Anti-thymocyte globulin - Mycophenolate mofetil - Tacrolimus immune suppression(2017)
Authors: Da Hae Lee, Geert Maleux, Chantal Mathieu, Pieter Gillard
Pages: 2218 - 2227 - Age and early graft function relate with risk-benefit ratio of allogenic islet transplantation under Anti-thymocyte globulin - Mycophenolate mofetil - Tacrolimus immune suppression(2017)
Authors: Da Hae Lee, Bart Keymeulen, Robert Hilbrands, Zhidong Ling, Ursule Van de Velde, Daniel Jacobs-Tulleneers-Thevissen, Geert Maleux, Bruno Lapauw, Laurent Crenier, Christophe De Block, et al.
Pages: 2218 - 2227 - Identification of Donor Origin and Condition of Transplanted Islets In Situ in the Liver of a Type 1 Diabetic Recipient(2017)
Authors: Da Hae Lee, Pieter Gillard
Pages: 1 - 9 - HLA-A*24 Carrier Status and Autoantibody Surges Posttransplantation Associate With Poor Functional Outcome in Recipients of an Islet Allograft(2016)
Authors: Pieter Gillard, Da Hae Lee
Pages: 1060 - 1064 - Hemoglobin A2-Leuven (α2δ2 143(H21) His>Asp): a novel delta-chain variant potentially interfering in hemoglobin A1c measurement using cation exchange HPLC(2016)
Authors: Davy Kieffer, Da Hae Lee, Pieter Gillard
Pages: E161 - E163 - Serum Cytokines as Biomarkers in Islet Cell Transplantation for Type 1 Diabetes(2016)
Authors: Da Hae Lee, Pieter Gillard
- Early Alteration of Kidney Function in Nonuremic Type 1 Diabetic Islet Transplant Recipients Under Tacrolimus-Mycophenolate Therapy(2014)
Authors: Pieter Gillard, Da Hae Lee, Dirk Kuypers, Chantal Mathieu
Pages: 451 - 7 - Minimal Functional β-Cell Mass in Intraportal Implants That Reduces Glycemic Variability in Type 1 Diabetic Recipients(2013)
Authors: Pieter Gillard, Da Hae Lee, Chantal Mathieu
Pages: 3483 - 8 - Reversible, Moderate and Early Alteration of Kidney Function in Non-Uremic Type 1 Diabetic Islet Recipients under Tacrolimus-Mycophenolate Maintenance Therapy(2013)
Authors: Pieter Gillard, Maria Rustandi, Da Hae Lee, Achmad Efendi, Zhidong Ling, Robert Hilbrands, Dirk Kuypers, Chantal Mathieu, Daniel Jacobs-Tulleneers-Thevissen, Frans Gorus, et al.
Pages: S90 - S90